Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: A multicenter phase II study
Open Access
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (10), 1127-1130
- https://doi.org/10.1023/a:1008497322508
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II studyEuropean Journal Of Cancer, 1996
- Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1995
- Paclitaxel (Taxol)New England Journal of Medicine, 1995
- Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: a phase II study.Journal of Clinical Oncology, 1994
- Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1993
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- Reporting results of cancer treatmentCancer, 1981